Prevail Innovative Wealth Advisors LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF $IHE

Prevail Innovative Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, Holdings Channel reports. The fund acquired 53,387 shares of the company’s stock, valued at approximately $4,529,000.

A number of other hedge funds have also recently modified their holdings of IHE. BNP Paribas Financial Markets bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at approximately $13,108,000. Anfield Capital Management LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $10,007,000. JPMorgan Chase & Co. grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 781.6% during the second quarter. JPMorgan Chase & Co. now owns 110,936 shares of the company’s stock valued at $7,271,000 after buying an additional 98,352 shares during the last quarter. Accurate Wealth Management LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $6,372,000. Finally, Banque Cantonale Vaudoise bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $2,077,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

IHE opened at $89.29 on Thursday. The stock has a market cap of $964.33 million, a price-to-earnings ratio of 17.75 and a beta of 0.49. The stock’s 50 day moving average price is $86.97 and its 200-day moving average price is $86.01. iShares U.S. Pharmaceuticals ETF has a one year low of $63.03 and a one year high of $92.29.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.